We quickly identified some major issues related to the company using their lead program, Glybera – the first gene therapy to be approved in the western world – as the foundation of their IPO. We repositioned the company around their platform and development capabilities, and set them up for success long-term.
Organizations we have served
Organizations we have launched
What we do
We build brands and implement communications strategies to help achieve your goals and objectives. We intimately know the audiences you want to reach including patients, clinicians, investors, partners, employees and the life science community at large.